The irregularities in the EGFR, a key factor in the development of NSCLC, include both genetic mutations within crucial EGFR regions and irregular DNA amplification, which are major contributors to the worsening of the disease and poor patient outcomes. Here, EGFR is linked to non-small cell lung carcinoma.